The World Health Organization (WHO) on Friday recommended two monoclonal antibody treatments against Ebola, saying the use of such drugs combined with better care had “revolutionized” the treatment of a disease once seen as a near-certain killer.
https://www.pharmalive.com/wp-content/uploads/2022/08/ReutersEbola8-192022.jpg9001200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-08-19 08:26:382022-08-19 10:23:32WHO recommends use of two antibody drugs against Ebola